Prevalence of Genetic Variants Associated with Sudden Cardiac Death in a Population Sample in Colombia

Cardiac channelopathies and cardiomyopathies are a group of cardiac disorders, they can be of both heritable and acquired genetic origin, which predispose affected individuals to sudden death as a result of changes in the expression or posttranslational modification of ion channels or alterations in associated proteins within the heart. 68 cases associated with sudden cardiac death were analyzed using the TruSight™Cardio sequencing panel, which contains 174 genes associated with heart disease. Variant filtering was performed taking into account the recommendations of ACC/AHA/ESC 2006, HRS/EHRA 2011 and HRS/EHRA/APHRS 2013. The study found a prevalence of cardiomyopathies of (40.6%), familial hypercholesterolemia with (5.4%), and cardiac channelopathies with (54%), in addition to the total of variants, 1.82% present conflict of interpretation of pathogenicity and 2.19% of uncertain significance, which should be studied in more detail in the future.

• Publication year

  2023

• Venue

  Journal of Clinical & Anatomic Pathology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.47275/2332-4864-126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal Cellular Phenotypes Induced by Three TMPO/LAP2 Variants Identified in Men with Cardiomyopathies

  2023cited by this paper
• Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies

  2022cited by this paper
• Identification of a novel missense mutation in the TPM1 gene via exome sequencing in a Chinese family with dilated cardiomyopathy

  2022cited by this paper
• Next-generation sequencing of postmortem molecular markers to support for medicolegal autopsy

  2022cited by this paper
• Cardiac involvement in two rare neuromuscular diseases: LAMA2-related muscular dystrophy and SELENON-related myopathy.

  2022cited by this paper
• Delayed Respiratory Insufficiency and Extramuscular Abnormalities in Selenoprotein N-Related Myopathies

  2021cited by this paper
• Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy

  2021cited by this paper
• Modeling Genetic Cardiac Channelopathies Using Induced Pluripotent Stem Cells - Status quo from an Electrophysiological Perspective.

  2021cited by this paper
• Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N

  2021cited by this paper
• MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning

  2021cited by this paper
• The application of big data to cardiovascular disease: paths to precision medicine.

  2020cited by this paper
• Abnormal

  2020cited by this paper
• Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy

  2020influential reference
• A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.

  2020cited by this paper
• An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia

  2020cited by this paper
• Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients

  2020cited by this paper
• Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers

  2020cited by this paper
• Rhapsody: predicting the pathogenicity of human missense variants

  2020cited by this paper
• Biophysical Investigation of Sodium Channel Interaction with β-Subunit Variants Associated with Arrhythmias

  2020cited by this paper
• Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants

  2020cited by this paper
• The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes.

  2020cited by this paper
• Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin

  2019cited by this paper
• Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts

  2019cited by this paper
• Structural Basis of Human KCNQ1 Modulation and Gating.

  2019cited by this paper
• Genetic testing in patients with hypertrophic cardiomyopathy.

  2019cited by this paper
• Genetic determinants of heart failure: facts and numbers

  2018cited by this paper
• Overexpression of the Cytokine BAFF and Autoimmunity Risk

  2017cited by this paper
• Sudden infant death syndrome caused by cardiac arrhythmias: only a matter of genes encoding ion channels?

  2016cited by this paper
• The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)

  2016cited by this paper
• University of Birmingham Combination of whole genome sequencing, linkage, and functional studies implicates a missense mutation in titin as a cause of autosomal dominant cardiomyopathy with features of left ventricular noncompaction

  2016cited by this paper
• Genetic Misdiagnoses and the Potential for Health Disparities.

  2016cited by this paper
• Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation☆

  2016cited by this paper
• Novel exon 1 protein‐coding regions N‐terminally extend human KCNE3 and KCNE4

  2016cited by this paper
• A Prospective Study of Sudden Cardiac Death among Children and Young Adults.

  2016cited by this paper
• Inherited arrhythmias: The cardiac channelopathies

  2015influential reference
• Genetics of channelopathies associated with sudden cardiac death

  2015cited by this paper
• A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield

  2015cited by this paper
• Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation.

  2015cited by this paper
• Determining the Pathogenicity of Genetic Variants Associated with Cardiac Channelopathies

  2015cited by this paper
• Post-mortem genetic analysis in juvenile cases of sudden cardiac death.

  2014cited by this paper
• Type 2 short QT syndrome and vestibular dysfunction: mirror of the Jervell and Lange-Nielsen syndrome?

  2014cited by this paper
• Diagnostic yield of clinical next-generation sequencing panels for epilepsy.

  2014cited by this paper
• TMEM43 Mutation p.S358L Alters Intercalated Disc Protein Expression and Reduces Conduction Velocity in Arrhythmogenic Right Ventricular Cardiomyopathy

  2014influential reference
• HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

  2013cited by this paper
• Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes

  2013cited by this paper
• Cardiac channelopathies: genetic and molecular mechanisms.

  2013cited by this paper
• Novel mutations in the TAZ gene in patients with Barth syndrome.

  2013cited by this paper
• Mutations of the SCN4B-encoded sodium channel β4 subunit in familial atrial fibrillation.

  2013cited by this paper
• Impact of genetics on the clinical management of channelopathies.

  2013cited by this paper
• Myofilament Ca Sensitization Increases Cytosolic Ca Binding Affinity, Alters Intracellular Ca Homeostasis, and Causes Pause-Dependent Ca-Triggered Arrhythmia

  2012cited by this paper
• Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.

  2012cited by this paper
• Selenoprotein N in skeletal muscle: from diseases to function

  2012cited by this paper
• Truncations of titin causing dilated cardiomyopathy.

  2012cited by this paper
• Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.

  2012influential reference
• The short QT syndrome: proposed diagnostic criteria.

  2011influential reference
• Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice

  2011cited by this paper
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011cited by this paper
• The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

  2009influential reference
• LUMA interacts with emerin and influences its distribution at the inner nuclear membrane

  2008influential reference
• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines

  2006cited by this paper
• Clinical and genetic issues in familial dilated cardiomyopathy.

  2005cited by this paper
• Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG

  2003cited by this paper
• Volume 8

  2001cited by this paper
• Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins.

  2000cited by this paper
• Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the Cardia Study

  1996cited by this paper
• A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

  1990cited by this paper
• Sudden cardiac death in adolescents.

  1985cited by this paper

• Genetic variants associated with sudden cardiac death in the young: a systematic review

  2025cites this paper